Stock listing
Sab Biotherapeutics, Inc.
Selected listing: SABS · NASDAQ · USD · US
Sab Biotherapeutics, Inc. (NASDAQ:SABS), Health Technology. Latest release Oct 1, 2026: SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D…
- Ticker
- NASDAQ:SABS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Sab Biotherapeutics, Inc.
Sab Biotherapeutics, Inc. (ticker: SABS) is a public company based in the United States, focused on developing innovative biotherapeutic products.
Latest news from Sab Biotherapeutics, Inc.
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
October 1, 2026
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
September 30, 2026
SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes
September 22, 2026
SAB BIO to Host Second Quarter 2026 Financial Results Conference Call and Webcast on August 6, 2026, 08:30 AM ET
July 30, 2026
Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes
July 7, 2026
Events
Research Sab Biotherapeutics, Inc.
Sab Biotherapeutics, Inc. company profile
View the public company page for Sab Biotherapeutics, Inc. on 6ix.
Sab Biotherapeutics, Inc. news
Read company news and market updates connected to Sab Biotherapeutics, Inc..
Sab Biotherapeutics, Inc. investor events
Find investor webinars, events, and replay context for Sab Biotherapeutics, Inc..